发明名称 |
Chondrocyte therapeutic delivery system |
摘要 |
Systems and methods for modifying the environment of target cell using genetically altered chondrocytes are provided. The genetically engineered chondrocytes can be used to express a therapeutic agent in a subject, including in an environment typically associated with chondrocytes and in an environment not typically associated with chondrocytes. |
申请公布号 |
US9125888(B2) |
申请公布日期 |
2015.09.08 |
申请号 |
US201213719792 |
申请日期 |
2012.12.19 |
申请人 |
DEPUY MITEK, LLC |
发明人 |
Story Brooks J.;Brown M. E. Liesbeth;Binette Francois |
分类号 |
A61K35/32;C12N5/077;A61L27/38;A61L27/54;A61K9/00;A61K35/12 |
主分类号 |
A61K35/32 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for modifying an environment of a target cell associated with a disorder using a genetically altered chondrocyte, comprising:
fully enclosing a genetically altered chondrocyte altered to express a therapeutic agent within one or more discrete semi-permeable containers, each having at least one chamber, the containers configured to retain the genetically altered chondrocyte while allowing passage of the therapeutic agent; and delivering the one or more containers to the environment of a target cell associated with a disorder; wherein the therapeutic agent is expressed and released from the one or more containers. |
地址 |
Raynham MA US |